Clinical Trial Update: Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2a study of RP-001 in participants with colorectal cancer or pancreatic cancer, with the trial status NOT_YET_RECRU…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• RP-001

Snippet

Sponsor: Recurv Pharma Inc | Conditions: Advanced Malignancies, Oncology | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING